Imbalances Between Interleukin-1 and Tumor Necrosis Factor Agonists and Antagonists in Stable COPD
- 17 March 2009
- journal article
- Published by Springer Science and Business Media LLC in Journal of Clinical Immunology
- Vol. 29 (4), 508-516
- https://doi.org/10.1007/s10875-009-9286-8
Abstract
Interleukin-1 beta (IL-1β) and tumor necrosis factor alpha (TNFα) are potentially important in Chronic Obstructive Pulmonary Disease (COPD), but little is known of the relationships between these cytokines and their antagonists in disease compared with healthy controls. It is unclear if concentrations relate to disease severity. The study aimed to investigate these relationships and to assess the potential activity of each cytokine in the context of their antagonists. Plasma cytokines, soluble receptors, and cell counts were measured in patients with stable COPD and age-matched healthy controls (n = 15 for both) daily for 5 days; these mediators were also measured in corresponding sputum samples from the COPD patients. COPD patients had significantly reduced concentrations of the antagonists, IL-1sRII, and IL-1RA compared with controls. In COPD, IL-1β exceeded its antagonists and correlated significantly with BMI and FEV1, while plasma IL-1RA correlated positively with BMI but negatively with sputum IL-1β, neutrophil, and macrophage counts and smoking history. TNFα antagonists exceeded agonists in both groups and did not correlate with COPD severity. Endogenous IL-1β antagonists appear reduced in COPD. Furthermore, IL-1β correlated with clinical aspects of disease severity, suggesting that IL-1β may play a critical role in COPD. Given the relevant concentrations and binding affinities, it is likely that TNFα has limited activity in stable COPD.This publication has 59 references indexed in Scilit:
- The TNFalpha gene relates to clinical phenotype in alpha-1-antitrypsin deficiencyRespiratory Research, 2008
- Tumour necrosis factor gene polymorphisms are associated with COPDEuropean Respiratory Journal, 2008
- Inter-relationships between inflammatory markers in patients with stable COPD with bronchitis: intra-patient and inter-patient variabilityThorax, 2007
- Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysisEuropean Respiratory Journal, 2007
- Variability of bronchial inflammation in chronic obstructive pulmonary disease: implications for study designEuropean Respiratory Journal, 2006
- Systemic inflammation in COPD visualised by gene profiling in peripheral blood neutrophilsThorax, 2005
- Imbalanced secretion of IL-1 and IL-1RA in Chlamydia pneumoniae-infected mononuclear cells from COPD patientsEuropean Respiratory Journal, 2003
- Symptom resolution assessed using a patient directed diary card during treatment of acute exacerbations of chronic bronchitisThorax, 2001
- Validation of assays for inflammatory mediators in sputumEuropean Respiratory Journal, 2000
- lnterleukin-1 Receptor AntagonistCritical Reviews™ in Immunology, 1995